Marburg Virus Disease (MVD)
Explore this page for Marburg Virus Disease information, resources, and news.
About Marburg Virus Disease (MVD)
According to the National Emerging Special Pathogens Training and Education Center (NETEC), "Marburg virus disease (MVD) is a rare but severe disease caused by infection with Marburg virus. Marburg is in the same viral family (filovirus) as Ebola, and the two diseases are clinically similar." According to the CDC, "Most Marburg virus disease outbreaks have occurred in Sub-Saharan Africa. However, the virus has spread to across the world through infected travelers or accidental laboratory infections."
There is currently no Food and Drug Administration (FDA)-approved vaccine or treatment for MVD. In the absence of early diagnosis and appropriate supportive care, MVD has a high mortality rate of 23%–90%.With early intensive supportive care and fluid replacement, mortality rates may be lower.
Explore
Tanzania 2025
- Jan. 22, 2025: NETEC: Situation Report
- Jan. 20, 2025 | Tanzania Declares Marburg Outbreak: Africa CDC Mobilizes Immediate Response | Africa CDC
- Jan. 15, 2025 | Possible Marburg Outbreak in the United Republic of Tanzania: Current Situation | CDC
Rwanda 2024
-
Jan. 22, 2025 | Marburg Virus Disease in Rwanda — Centering Both Evidence and Equity
- According to the WHO, the Marburg outbreak in Rwanda was declared over on December 20, 2024.
Equatorial Guinea & Tanzania 2023
- Equatorial Guinea and Tanzania delcared the end of the Marburg outbreak in May and June 2023, respectively.